Trial intelligence / Profile preview

Skin penetration of dexamethasone and tacrolimus in lesional versus non-lesional skin in psoriasis

2016-003802-14Phase 4Terminated

Sponsor
Charité – Universitätsmedizin Berlin
Start
Oct 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexamethasone, tacrolimus in plaque psoriasis, sponsored by Charité – Universitätsmedizin Berlin. Started Oct 2016; status: terminated.

02

Drugs

dexamethasonetacrolimus
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on 2016-003802-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-003802-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call